David A. Scott

机构：Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center · ORCID：0000-0003-3243-528X

发表论文 108 篇 · 总被引 2726 次 · h-index 24

代表论文

• From hit to vial: Precision discovery and development of an imidazopyrimidine TLR7/8 agonist adjuvant formulation (2024 · Science Advances · 被引 17)
• A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma (2024 · Cancer Research · 被引 11)
• Tilting the Scales toward EGFR Mutant Selectivity: Expanding the Scope of Bivalent “Type V” Kinase Inhibitors (2024 · Journal of Medicinal Chemistry · 被引 9)
• Allosteric inhibition of JAK2 with lysine-reactive compounds that bind the pseudokinase domain (2025 · European Journal of Medicinal Chemistry · 被引 4)
• RAF isoform selectivity of MEK inhibitors and rational design of a covalent ARAF-MEK inhibitor (2025 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 1)
• Allosteric Inhibition of Jak2 with Lysine-Reactive Compounds that Bind the Pseudokinase Domain (2025 · SSRN Electronic Journal)